Following the observation that high CYP27A1 expression predicts better prognosis in premenopausal patients with ER+ BC, we next explored in vitro whether the growth inhibitory effects of 27HC in the presence of estrogen was dependent on the availability of other serum lipids. Here, CYP27A1 is linked to breast cancer.